1. Home
  2. ANGO
  3. ANGO News

Latest AngioDynamics Inc. (ANGO) News on September 12, 2025

What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings
ANGO

GuruFocus.com

2 months ago

What To Expect From AngioDynamics Inc (ANGO) Q4 2025 Earnings

ANGO

Business Wire

3 months ago

AngioDynamics Announces First Patient Enrolled in RECOVER-AV Clinical Trial Evaluating AlphaVac F1885 System for Treatment of Acute Pulmonary Embolism

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
ANGO

Zacks

3 months ago

Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma
ANGO

Zacks

3 months ago

VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma

INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach
ANGO

Zacks

3 months ago

INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach

ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite
ANGO

Zacks

3 months ago

ZimVie Stock Gains Following the Launch of RealGUIDE Software Suite

Zacks Industry Outlook Penumbra, Integer and AngioDynamics
ANGO

Zacks

3 months ago

Zacks Industry Outlook Penumbra, Integer and AngioDynamics

NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
ANGO

Zacks

3 months ago

NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial

3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom
ANGO

Zacks

3 months ago

3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom

Here's Why You Should Add PacBio Stock to Your Portfolio Now
ANGO

Zacks

3 months ago

Here's Why You Should Add PacBio Stock to Your Portfolio Now

Reasons to Add Fresenius Medical Stock to Your Portfolio Now
ANGO

Zacks

3 months ago

Reasons to Add Fresenius Medical Stock to Your Portfolio Now

What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now?
ANGO

Zacks

3 months ago

What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now?

Are Medical Stocks Lagging AngioDynamics (ANGO) This Year?
ANGO

Zacks

3 months ago

Are Medical Stocks Lagging AngioDynamics (ANGO) This Year?

Here's Why You Should Add HealthEquity Stock to Your Portfolio Now
ANGO

Zacks

3 months ago

Here's Why You Should Add HealthEquity Stock to Your Portfolio Now

NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial
ANGO

Zacks

3 months ago

NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial

Reasons to Retain Veeva Systems Stock in Your Portfolio for Now
ANGO

Zacks

3 months ago

Reasons to Retain Veeva Systems Stock in Your Portfolio for Now

BioSig Stock Surges Following Share Exchange Deal With Streamex
ANGO

Zacks

4 months ago

BioSig Stock Surges Following Share Exchange Deal With Streamex

Reasons to Retain TransMedics Stock in Your Portfolio for Now
ANGO

Zacks

4 months ago

Reasons to Retain TransMedics Stock in Your Portfolio for Now

AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech
ANGO

Zacks

4 months ago

AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech

BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
ANGO

Zacks

4 months ago

BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad

SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System
ANGO

Zacks

4 months ago

SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
ANGO

Zacks

4 months ago

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

AngioDynamics (ANGO) Down 6.4% Since Last Earnings Report: Can It Rebound?
ANGO

Zacks

4 months ago

AngioDynamics (ANGO) Down 6.4% Since Last Earnings Report: Can It Rebound?

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?
ANGO

Zacks

4 months ago

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?

LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7
ANGO

Zacks

5 months ago

LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7

Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year?
ANGO

Zacks

5 months ago

Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year?

Shareholders in AngioDynamics (NASDAQ:ANGO) are in the red if they invested three years ago
ANGO

Simply Wall St.

5 months ago

Shareholders in AngioDynamics (NASDAQ:ANGO) are in the red if they invested three years ago

Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 68.28%: Read This Before Placing a Bet
ANGO

Zacks

5 months ago

Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 68.28%: Read This Before Placing a Bet

AngioDynamics Stock Up on Q3 Earnings Beat, Gross Margin Expands
ANGO

Zacks

5 months ago

AngioDynamics Stock Up on Q3 Earnings Beat, Gross Margin Expands

AngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
ANGO

GuruFocus.com

5 months ago

AngioDynamics Inc (ANGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

ANGO

Thomson Reuters StreetEvents

5 months ago

Q3 2025 AngioDynamics Inc Earnings Call

AngioDynamics (ANGO) Tops Q3 Earnings and Revenue Estimates
ANGO

Zacks

5 months ago

AngioDynamics (ANGO) Tops Q3 Earnings and Revenue Estimates

ANGO

Associated Press Finance

5 months ago

AngioDynamics: Fiscal Q3 Earnings Snapshot

ANGO

Business Wire

5 months ago

AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial Results

ANGO

Business Wire

5 months ago

AngioDynamics to Host Virtual Cardiovascular Investor Event

Are Medical Stocks Lagging Gilead Sciences (GILD) This Year?
ANGO

Zacks

6 months ago

Are Medical Stocks Lagging Gilead Sciences (GILD) This Year?

ANGO

Business Wire

6 months ago

AngioDynamics to Report Fiscal 2025 Third Quarter Financial Results on April 2, 2025 and Host Virtual Cardiovascular Investor Event

MMSI Announces Commencement of Patient Enrollment in PREEMIE Study
ANGO

Zacks

6 months ago

MMSI Announces Commencement of Patient Enrollment in PREEMIE Study

ANGO

Business Wire

6 months ago

AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference

Several Insiders Invested In AngioDynamics Flagging Positive News
ANGO

Simply Wall St.

7 months ago

Several Insiders Invested In AngioDynamics Flagging Positive News

AngioDynamics (ANGO) Down 14.2% Since Last Earnings Report: Can It Rebound?
ANGO

Zacks

7 months ago

AngioDynamics (ANGO) Down 14.2% Since Last Earnings Report: Can It Rebound?

ANGO Stock Looks Promising on New Ischemia Study for Auryon System
ANGO

Zacks

7 months ago

ANGO Stock Looks Promising on New Ischemia Study for Auryon System

ANGO

Business Wire

7 months ago

AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia

With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns
ANGO

Simply Wall St.

8 months ago

With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns

ANGO

Business Wire

8 months ago

AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI

AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines
ANGO

Zacks

8 months ago

AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines

AngioDynamics Reports Growth and Advances NanoKnife System
ANGO

TipRanks

8 months ago

AngioDynamics Reports Growth and Advances NanoKnife System

AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
ANGO

GuruFocus.com

8 months ago

AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

ANGO

Thomson Reuters StreetEvents

8 months ago

Q2 2025 AngioDynamics Inc Earnings Call

ANGO

MT Newswires

8 months ago

AngioDynamics Shares Jump Following Fiscal Q2 Results

AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
ANGO

Zacks

8 months ago

AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates

ANGO

Associated Press Finance

8 months ago

AngioDynamics: Fiscal Q2 Earnings Snapshot

ANGO

Business Wire

8 months ago

AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results

What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings
ANGO

GuruFocus.com

8 months ago

What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings

ANGO

Business Wire

8 months ago

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

ANGO

Business Wire

8 months ago

AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System

ANGO

Business Wire

9 months ago

AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife
ANGO

Zacks

9 months ago

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength?
ANGO

Zacks

9 months ago

Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength?

NanoKnife gains FDA clearance for prostate tissue ablation
ANGO

Medical Device Network

9 months ago

NanoKnife gains FDA clearance for prostate tissue ablation

ANGO

MT Newswires

9 months ago

AngioDynamics' NanoKnife System Receives FDA Clearance for Prostate Tissue Ablation

ANGO

Business Wire

9 months ago

AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation

NARI Stock Likely to Gain Following Reimbursement Approval in Japan
ANGO

Zacks

9 months ago

NARI Stock Likely to Gain Following Reimbursement Approval in Japan

STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System
ANGO

Zacks

10 months ago

STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System

NVRO Stock Declines Despite Positive Study Data of Nevro1 System
ANGO

Zacks

10 months ago

NVRO Stock Declines Despite Positive Study Data of Nevro1 System

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
ANGO

Zacks

10 months ago

INBS Stock Declines Despite Positive Results of Pharmacokinetic Study

Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates
ANGO

Zacks

10 months ago

Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates

Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to Trade
ANGO

Zacks

10 months ago

Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to Trade

GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
ANGO

Zacks

10 months ago

GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up

Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 77% over the last three years
ANGO

Simply Wall St.

10 months ago

Investors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 77% over the last three years

AngioDynamics Stock Plunges 13.8% in Three Months: What's Next?
ANGO

Zacks

10 months ago

AngioDynamics Stock Plunges 13.8% in Three Months: What's Next?

AngioDynamics launches long-term study of NanoKnife for prostate cancer
ANGO

Clinical Trials Arena

a year ago

AngioDynamics launches long-term study of NanoKnife for prostate cancer

ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE
ANGO

Zacks

a year ago

ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE

ANGO

Business Wire

a year ago

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments
ANGO

Medical Device Network

a year ago

AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments

ANGO

Business Wire

a year ago

AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver

ANGO

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 10/11/2024

ANGO

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 10/09/2024

AngioDynamics (ANGO) Loses -15.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ANGO

Zacks

a year ago

AngioDynamics (ANGO) Loses -15.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise
ANGO

Zacks

a year ago

AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise

AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025
ANGO

TipRanks

a year ago

AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025

ANGO

Thomson Reuters StreetEvents

a year ago

Q1 2025 AngioDynamics Inc Earnings Call

AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ...
ANGO

GuruFocus.com

a year ago

AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ...

Why AngioDynamics Stock Is Crashing Today
ANGO

Motley Fool

a year ago

Why AngioDynamics Stock Is Crashing Today

Here's Why You Should Add AngioDynamics Stock to Your Portfolio
ANGO

Zacks

a year ago

Here's Why You Should Add AngioDynamics Stock to Your Portfolio

AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates
ANGO

Zacks

a year ago

AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates

ANGO

Associated Press Finance

a year ago

AngioDynamics: Fiscal Q1 Earnings Snapshot

ANGO

Business Wire

a year ago

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

AngioDynamics Inc (ANGO) Q1 2025 Earnings Report Preview: What To Expect
ANGO

GuruFocus.com

a year ago

AngioDynamics Inc (ANGO) Q1 2025 Earnings Report Preview: What To Expect

New Strong Buy Stocks for September 30th
ANGO

Zacks

a year ago

New Strong Buy Stocks for September 30th

ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe
ANGO

Zacks

a year ago

ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe

AngioDynamics initiates thrombectomy system trial across Europe
ANGO

Medical Device Network

a year ago

AngioDynamics initiates thrombectomy system trial across Europe

ANGO

MT Newswires

a year ago

AngioDynamics Starts Trial of AlphaVac System in Pulmonary Embolism Treatment

ANGO

Business Wire

a year ago

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

ANGO

Business Wire

a year ago

AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024

This AngioDynamics Insider Increased Their Holding In The Last Year
ANGO

Simply Wall St.

a year ago

This AngioDynamics Insider Increased Their Holding In The Last Year

New Strong Buy Stocks for September 9th
ANGO

Zacks

a year ago

New Strong Buy Stocks for September 9th

AngioDynamics Stock Falls Despite CE Mark for Auryon System
ANGO

Zacks

a year ago

AngioDynamics Stock Falls Despite CE Mark for Auryon System

AngioDynamics wins EU CE mark for Auryon system to treat PAD
ANGO

Medical Device Network

a year ago

AngioDynamics wins EU CE mark for Auryon system to treat PAD

ANGO

Business Wire

a year ago

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

Share on Social Networks: